November 14, 2011, The United Laboratories International Holdings Limited (“TUL”) issued CNY 790 million USD settled convertible bonds which will be due in 2016.

TUL possesses advanced production equipments and integrates research and development of drugs, production and operation into one entity, from the fermentation of biological materials to the production of intermediate products, bulk medicine, and finished products as well as packaging of drugs and related materials.  At TUL, a vertically integrated production and operation model is adopted.

 Jingtian & Gongcheng represented the underwriter in the issuance.